Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DC5A9Q
|
|||
Drug Name |
mRNA-2752
|
|||
Synonyms |
mRNA-OX40L/IL-23/IL-36 gamma
Click to Show/Hide
|
|||
Drug Type |
mRNA therapy
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
Company |
Moderna Therapeutics
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Interleukin-23 (IL23) | Target Info | Replacement | [2] |
Interleukin-36 gamma (IL36G) | Target Info | Replacement | [2] | |
TAX transcriptionally-activated glycoprotein 1 (OX40) | Target Info | Replacement | [2] | |
KEGG Pathway | Cytokine-cytokine receptor interaction | |||
Toll-like receptor signaling pathway | ||||
RIG-I-like receptor signaling pathway | ||||
Jak-STAT signaling pathway | ||||
Type I diabetes mellitus | ||||
Pertussis | ||||
Legionellosis | ||||
Leishmaniasis | ||||
Chagas disease (American trypanosomiasis) | ||||
African trypanosomiasis | ||||
Malaria | ||||
Toxoplasmosis | ||||
Amoebiasis | ||||
Tuberculosis | ||||
Measles | ||||
Influenza A | ||||
Herpes simplex infection | ||||
Inflammatory bowel disease (IBD) | ||||
Allograft rejection | ||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
TSLP Signaling Pathway | ||||
Reactome | TNFs bind their physiological receptors | |||
WikiPathways | Toll-like receptor signaling pathway | |||
Aryl Hydrocarbon Receptor Pathway | ||||
Allograft Rejection | ||||
Regulation of toll-like receptor signaling pathway | ||||
Vitamin D Receptor Pathway | ||||
TSLP Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03739931) Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants With Advanced Malignancies. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Moderna Therapeutics. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.